Search

Your search keyword '"Ricci, Daniela"' showing total 67 results

Search Constraints

Start Over You searched for: Author "Ricci, Daniela" Remove constraint Author: "Ricci, Daniela" Database Academic Search Index Remove constraint Database: Academic Search Index
67 results on '"Ricci, Daniela"'

Search Results

1. From Bacterial Toxin to Therapeutic Agent: The Unexpected Fate of Mycolactone.

2. ERp57 chaperon protein protects neuronal cells from Aβ‐induced toxicity.

3. The special unfolded protein response in plasma cells.

4. An interdomain helix in IRE1a mediates the conformational change required for the sensor's activation.

5. Land Rush, pratique documentaire et regard sur la complexité du réel.

6. Clustering of IRE1α depends on sensing ER stress but not on its RNase activity.

7. Increased activity of IRE1 improves the clinical presentation of EAE.

8. Novel evidence of Thymosin α1 immunomodulatory properties in SARS-CoV-2 infection: Effect on innate inflammatory response in a peripheral blood mononuclear cell-based in vitro model.

9. Use of the Hammersmith Infant Neurological Examination in infants with cerebral palsy: a critical review of the literature.

10. Outlining a core neuropsychological phenotype for Dravet syndrome.

11. Green tea catechins can bind and modify ERp57/PDIA3 activity

12. Visual function assessment in late-preterm newborns

13. The forward parachute reaction and independent walking in infants with brain lesions.

14. Early visual assessment in preterm infants with and without brain lesions: Correlation with visual and neurodevelopmental outcome at 12months

15. Early development in Dravet syndrome; visual function impairment precedes cognitive decline

16. Early assessment of visual function in preterm infants: How early is early?

17. Neurological examination of preterm infants at term equivalent age

18. Application of a neonatal assessment of visual function in a population of low risk full-term newborn

19. Early assessment of visual function in full term newborns

20. Visual development in infants with prenatal post-haemorrhagic ventricular dilatation.

21. Thalamic atrophy in infants with PVL and cerebral visual impairment

22. The neurological examination of the newborn baby

23. Head Growth in Infants With Hypoxic-Ischemic Encephalopathy.

24. Neurological assessment tool for screening infants during the first year after birth: The Brief‐Hammersmith Infant Neurological Examination.

25. Innate Immune Response to SARS-CoV-2 Infection: From Cells to Soluble Mediators.

26. Visual Function and Ophthalmological Findings in CHARGE Syndrome: Revision of Literature, Definition of a New Clinical Spectrum and Genotype Phenotype Correlation.

27. The Sensor IRE1 Couples Stress Detection to Protein Synthesis.

28. Visual performance and brain structures in the developing brain of pre-term infants

29. Early visual and neuro-development in preterm infants with and without retinopathy.

30. Typical Crossmodal Numerosity Perception in Preterm Newborns.

31. Human plasmacytoid dendritic cells at the crossroad of type I interferon-regulated B cell differentiation and antiviral response to tick-borne encephalitis virus.

33. Perinatal brain lesions and cognitive outcome.

34. Visual Function in Children with GNAO1-Related Encephalopathy.

35. A specific anti‐COVID‐19 BNT162b2 vaccine‐induced early innate immune signature positively correlates with the humoral protective response in healthy and multiple sclerosis vaccine recipients.

36. Neurological and visual assessments in very and late low-risk preterm infants

37. Visual Function at 35 and 40 Weeks' Postrnenstrual Age in Low-Risk Preterm Infants.

38. Bernhard Sabel and 'Residual Vision Activation Theory': a History Spanning Three Decades.

40. Hammersmith Infant Neurological Examination in infants born at term: Predicting outcomes other than cerebral palsy.

41. A Haptic Nonverbal Cognitive Test for Children and Adolescents With Visual Impairment.

42. Short- and mid-term multidisciplinary outcomes of newborns exposed to SARS-CoV-2 in utero or during the perinatal period: preliminary findings.

43. Development of clinical signs in low risk term born infants with neonatal hyperexcitability

44. Development of Visual Attention in West Syndrome.

45. Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection.

46. Hammersmith Infant Neurological Examination for infants born preterm: predicting outcomes other than cerebral palsy.

47. Visual Function Classification System for children with cerebral palsy: development and validation.

48. Follow-up to Age 4 Years of Treatment of Type 1 Retinopathy of Prematurity Intravitreal Bevacizumab Injection versus Laser: Fluorescein Angiographic Findings.

49. Neonatal neurological examination during the first 6h after birth.

50. Correction to: Short‑ and mid‑term multidisciplinary outcomes of newborns exposed to SARS‑CoV‑2 in utero or during the perinatal period: preliminary findings.

Catalog

Books, media, physical & digital resources